Deformylase as a novel antibacterial target

Drug Discovery Today

Volumn 6, Issue 18, 2001, Pages 954-961

  Yuan, Zhengyu ^a   Trias, Joaquim ^a   White, Richard J ^a  

^a Versicor Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINORIN; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BACTERIAL PROTEIN; BETA SOLFINYLHYDROXAMIC ACID; BIARYL ACID; DEFORMYLASE; DEFORMYLASE INHIBITOR; ENZYME INHIBITOR; N (1 TERT BUTYL 2 DIMETHYLAMINO 2 OXOETHYL) 2 (N FORMYL N HYDROXYAMINOMETHYL)HEXANAMIDE; PEPTIDE ALDEHYDE; PEPTIDE DEFORMYLASE; PEPTIDE DEFORMYLASE INHIBITOR; PHOSPHONIC ACID DERIVATIVE; THIOPEPTIDE; UNCLASSIFIED DRUG; VRC 3324;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; BACTERIAL GENETICS; BACTERIAL METABOLISM; DRUG RESEARCH; DRUG RESISTANCE; DRUG TARGETING; ENZYME INHIBITION; EUKARYOTE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; REVIEW;

EID: 0035885234     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01925-0     Document Type: Review

References (50)

1. Global transposon mutagenesis and a minimal Mycoplasma genome
2. Inhibitors of protein synthesis
3. A survey of polypeptide deformylase function throughout the eubacterial lineage
4. Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation
5. N-formylmethionyl-sRNA as the initiator of protein synthesis
6. Initiation of protein synthesis in isolated mitochondria and chloroplasts
7. Methionine as translation start signal: a review of the enzymes of the pathway in Escherichia coli
8. Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents
9. Characterization of the Thermus thermophilus locus encoding peptide deformylase and methionyl-tRNA(fMet) formyltransferase
10. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene
11. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB
12. Formylation is not essential for initiation of protein synthesis in all eubacteria
13. Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion
14. Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents?
15. Enzymes degrading bacterial chemotactic F-met peptides in human ileal and colonic mucosa
16. Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms
17. Physiological role of the N-terminal processed P4501A1 targeted to mitochondria in erythromycin metabolism and reversal of erythromycin-mediated inhibition of mitochondrial protein synthesis
18. On the release of the formyl group from nascent protein
19. Evidence that peptide deformylase and methionyl-tRNA(fMet) formyltransferase are encoded within the same operon in Escherichia coli
20. Enzymatic properties of Escherichia coli peptide deformylase
21. Peptide deformylase, a new type of mononuclear iron protein
22. Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site
23. Oxygen-mediated inactivation of peptide deformylase
24. Iron center, substrate recognition and mechanism of peptide deformylase
25. Substrate recognition and selectivity of peptide deformylase. Similarities and differences with metzincins and thermolysin
26. Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133
27. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor
28. Design and synthesis of substrate analogue inhibitors of peptide deformylase
29. Synthesis and antibacterial activity of peptide deformylase inhibitors
30. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents
31. Antibiotic activity and characterization of BB3497, a novel peptide deformylase inhibitor
32. Novel nonpeptidic inhibitors of peptide deformylase
33. H-phosphonate derivatives as novel peptide deformylase inhibitors
34. Protease inhibitors: current status and future prospects
35. Angiotensin-converting enzyme inhibitors: medicinal chemistry and biological actions
36. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on Batimastat and Marimastat
37. Structure of peptide deformylase and identification of the substrate binding site
38. A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase
39. Crystal structure of the Escherichia coli peptide deformylase
40. Structural basis for the design of antibiotics targeting peptide deformylase
41. Solution structure of nickel-peptide deformylase
42. Actinonin: an antibiotic substance produced by an Actinomycete
43. Peptide deformylase as an antibacterial drug target: target validation and resistance development
44. Studies concerning the antibiotic actinonin. Part VIII. Structure-activity relationships in the actinonin series
45. Inhibition of bacterial peptide deformylase by biaryl acid analogs
46. Peptide aldehyde inhibitors of bacterial peptide deformylases